Synthetic method of ascorbyl tetraisopalmitate
The synthesis of ascorbic acid tetraisopalmitate via transesterification solves the problems of complex use and purification of acylation reagents in traditional methods, achieving high-purity and high-yield synthesis suitable for industrial production.
Patent Information
- Application Number
- CN202411130554.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-16
- Publication Date
- 2024-11-26
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Existing technologies require the use of highly toxic acylation reagents in the synthesis of ascorbic acid tetraisopalmitate, and the subsequent purification process is complex, which is not conducive to industrial production.
Ascorbate tetraisopalmitate was synthesized in one step by transesterification of methyl 2-hexyldecanoate and vitamin C, followed by extraction, washing, drying, decolorization and purification. Acylating agents and strong oxidizing agents were avoided. Catalysts such as dibutyltin oxide and DMAP were used to optimize the reaction conditions and purification steps.
A safe and reliable synthesis of ascorbic acid tetraisopalmitate was achieved, improving purity and yield, simplifying the operation process, and making it suitable for industrial production.
Smart Images

Figure CN119019349A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of fine chemical synthesis, in particular to a method for synthesizing ascorbyl tetraisopalmitate. Background Art
[0002] Vitamin C and its derivatives have antioxidant and whitening effects in cosmetics, and can effectively inhibit the formation of melanin and scavenge free radicals. However, due to the instability, easy discoloration, low ester solubility and poor absorption of vitamin C, it is difficult to be widely used in cosmetics.
[0003] Ascorbyl tetraisopalmitate is an important fat-soluble vitamin C derivative, which is milder and more stable than traditional vitamin C. Its excellent lipophilicity allows it to penetrate into the skin efficiently and dissociate into vitamin C in the skin to achieve its tyrosinase inhibition effect.
[0004] At present, most of the domestic synthesis methods of ascorbic acid tetraisopalmitate adopt a two-step method: Chinese patent CN202211330946.5 synthesizes acyl chloride through an acylating agent and then condenses it with vitamin C. This method requires the use of a highly toxic acylating agent, and the subsequent purification process is complicated and highly harmful to the equipment. Therefore, it is not conducive to industrial amplification production. Therefore, those skilled in the art provide a method for synthesizing ascorbic acid tetraisopalmitate to solve the problems raised in the above background technology. Summary of the invention
[0005] The object of the present invention is to provide a method for synthesizing ascorbyl tetraisopalmitate to solve the problems mentioned above.
[0006] To achieve the above object, the present invention provides the following technical solutions:
[0007] A method for synthesizing ascorbyl tetraisopalmitate comprises the following steps:
[0008] Step (1), dissolving methyl 2-hexyldecanoate, vitamin C, and a catalyst in an organic solvent to obtain a suspension solution;
[0009] Step (2), heating the suspension to reflux and reacting at the reflux temperature for 4 to 10 hours;
[0010] Step (3), after the reaction is completed, the temperature is lowered to room temperature, and the reaction solution is extracted twice to remove the unreacted 2-hexyldecanoic acid methyl ester;
[0011] Step (4), after extraction, add water to wash twice to remove the unreacted vitamin C. After washing, add anhydrous magnesium sulfate to dry, and filter to remove magnesium sulfate;
[0012] Step (5), activated carbon is added to the filtrate for decolorization. After the decolorization is complete, the filtrate is concentrated. The crude product is purified by a column and concentrated to dryness to obtain a colorless transparent oily liquid, i.e., ascorbyl tetraisopalmitate.
[0013] As a further scheme of the present invention: in step (1), the molar ratio of vitamin C to 2-hexyldecanoic acid methyl ester and the catalyst is 1:4.0-5.0:0.1-1.0. The further optimized molar ratio is 1:4.2-4.5:0.1-0.5. The organic solvent is one or more of n-hexane, n-heptane, and n-octane. In further optimization, the organic solvent is n-heptane. The type of the transesterification alkaline catalyst is one or more of dibutyltin oxide, DMAP, alkaline resin, etc. The further optimized catalyst is DMAP.
[0014] As a further solution of the present invention: the reaction time in step (2) is 4 to 10 hours, and the further optimized reaction time is 5 to 7 hours.
[0015] As a further solution of the present invention: the extraction liquid described in step (3) is one or more of methanol, ethanol, n-octanol, etc., and the further optimized extraction liquid is methanol.
[0016] As a further solution of the present invention: the amount of anhydrous magnesium sulfate added in step (4) is 0.5% to 10% of the weight of the reaction solution, and the further optimized amount is 4% to 5%.
[0017] As a further solution of the present invention: the amount of activated carbon added in step (5) is 0.1% to 10% of the weight of the reaction solution, and the further optimized amount of activated carbon added is 1.0% to 2.0%.
[0018] As a further solution of the present invention: the ratio of the column purification eluent in step (5) is petroleum ether: normal hexane = 1: 1-50, and the further optimized ratio of the eluent is petroleum ether: normal hexane = 1: 20-30.
[0019] Compared with the prior art, the present invention has the following beneficial effects:
[0020] The invention utilizes 2-hexyldecanoic acid methyl ester and vitamin C to carry out ester exchange reaction to generate ascorbyl tetraisopalmitate, and obtains a colorless transparent oily liquid after extraction, water washing, drying, decolorization, purification and concentration. The method can synthesize ascorbyl tetraisopalmitate in one step, avoids the use of acylating agents and strong oxidizing agents, is equipment-friendly, has safe and reliable operating conditions, and is easy to industrially scale up production. BRIEF DESCRIPTION OF THE DRAWINGS
[0021] Figure 1The figure is the hydrogen nuclear magnetic resonance spectrum of ascorbyl tetraisopalmitate prepared by this method.
[0022] Figure 2 The figure is the high performance liquid chromatogram of ascorbyl tetraisopalmitate prepared by this method. DETAILED DESCRIPTION
[0023] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0024] See also Figures 1-2 In an embodiment of the present invention, a method for synthesizing ascorbyl tetraisopalmitate comprises the following steps:
[0025] Step (1), dissolving methyl 2-hexyldecanoate, vitamin C, and a catalyst in an organic solvent to obtain a suspension solution;
[0026] Step (2), heating the suspension to reflux and reacting at the reflux temperature for 4 to 10 hours;
[0027] Step (3), after the reaction is completed, the temperature is lowered to room temperature, and the reaction solution is extracted twice to remove the unreacted 2-hexyldecanoic acid methyl ester;
[0028] Step (4), after extraction, add water to wash twice to remove the unreacted vitamin C. After washing, add anhydrous magnesium sulfate to dry, and filter to remove magnesium sulfate;
[0029] Step (5), activated carbon is added to the filtrate for decolorization. After the decolorization is complete, the filtrate is concentrated. The crude product is purified by a column and concentrated to dryness to obtain a colorless transparent oily liquid, i.e., ascorbyl tetraisopalmitate.
[0030] By adopting the above technical scheme, ascorbic acid tetraisopalmitate can be synthesized in one step, avoiding the use of acylating agents and strong oxidizing agents, being equipment-friendly, and having safe and reliable operating conditions, and being easy to scale up industrial production.
[0031] Wherein, in step (1), the molar ratio of vitamin C to 2-hexyldecanoic acid methyl ester and catalyst is 1:4.0-5.0:0.1-1.0. The further optimized molar ratio is 1:4.2-4.5:0.1-0.5. The organic solvent is one or more of n-hexane, n-heptane and n-octane, and the organic solvent is further optimized to be n-heptane. The type of the transesterification alkaline catalyst is one or more of dibutyltin oxide, DMAP, alkaline resin, etc. The further optimized catalyst is DMAP.
[0032] The reaction time in step (2) is 4 to 10 hours, and the further optimized reaction time is 5 to 7 hours; the extracting liquid in step (3) is one or more of methanol, ethanol, n-octanol, etc., and the further optimized extracting liquid is methanol; the addition amount of anhydrous magnesium sulfate in step (4) is 0.5% to 10% of the weight of the reaction liquid, and the further optimized addition amount is 4% to 5%; the addition amount of activated carbon in step (5) is 0.1% to 10% of the weight of the reaction liquid, and the further optimized addition amount of activated carbon is 1.0% to 2.0%; the ratio of the column purification eluent in step (5) is petroleum ether: n-hexane = 1: 1 to 50, and the further optimized ratio of the eluent is petroleum ether: n-hexane = 1: 20 to 30.
[0033] Example 1
[0034] At room temperature, 880g of n-hexane was added to a 2L four-necked flask. Under stirring, 88g of vitamin C (500mmol), 24.88g of dibutyltin oxide (100mmol), and 567.56g of methyl 2-hexyldecanoate (2.1mol) were added in batches. After stirring for 10min, the temperature was raised to reflux, and the reaction was continued at the secondary temperature for 8h. After the reaction was completed, it was cooled to room temperature, 220g of methanol was added, and the mixture was extracted twice. 220g of water was added and washed twice. Subsequently, 70g of anhydrous magnesium sulfate was added, and the anhydrous magnesium sulfate was removed by filtering after stirring for 30min. Subsequently, 30g of activated carbon was added, and the activated carbon was removed by filtering after stirring for 30min. After concentration, column purification was performed (the ratio of eluent was petroleum ether: n-hexane = 1:20). After elution and concentration, 460.35g of colorless transparent liquid was obtained, with a purity of 98.83% and a yield of 81.55%.
[0035] Example 2
[0036] At room temperature, 880g of n-heptane was added to a 2L four-necked flask. Under stirring, 88g of vitamin C (500mmol), 24.42g of DMAP (100mmol), and 567.56g of 2-hexyldecanoic acid methyl ester (2.1mol) were added in batches. After stirring for 10min, the temperature was raised to reflux, and the reaction was continued at the sub-temperature for 8h. After the reaction was completed, the temperature was lowered to room temperature, 220g of methanol was added, and the mixture was extracted twice. 220g of water was added and washed twice. Subsequently, 70g of anhydrous magnesium sulfate was added, and the anhydrous magnesium sulfate was removed by filtration after stirring for 30min. Subsequently, 30g of activated carbon was added, and the activated carbon was removed by filtration after stirring for 30min. After concentration, column purification was performed (the ratio of eluent was petroleum ether: n-hexane = 1:20). After elution and concentration, 475.47g of colorless transparent liquid was obtained, with a purity of 99.23% and a yield of 84.23%.
[0037] Example 3
[0038] At room temperature, 880g of n-heptane was added to a 2L four-necked flask. Under stirring, 88g of vitamin C (500mmol), 24.42g of DMAP (100mmol), and 594.58g of 2-hexyldecanoic acid methyl ester (2.2mol) were added in batches. After stirring for 10min, the temperature was raised to reflux, and the reaction was continued at the secondary temperature for 10h. After the reaction was completed, the temperature was lowered to room temperature, 440g of methanol was added, and the mixture was extracted twice. 220g of water was added and washed twice. Subsequently, 70g of anhydrous magnesium sulfate was added, and the anhydrous magnesium sulfate was removed by filtration after stirring for 30min. Subsequently, 30g of activated carbon was added, and the activated carbon was removed by filtration after stirring for 30min. After concentration, column purification was performed (the ratio of eluent was petroleum ether: n-hexane = 1:20). After elution and concentration, 479.03g of colorless transparent liquid was obtained, with a purity of 99.13% and a yield of 84.86%.
[0039] Example 4
[0040] At room temperature, 8.8 kg of n-heptane was added to a 20L four-necked flask. Under stirring, 880 g of vitamin C (5.0 mol), 366.26 g of DMAP (3.0 mmol), and 5.95 kg of 2-hexyldecanoic acid methyl ester (22.0 mol) were added in batches. After stirring for 10 min, the temperature was raised to reflux, and the reaction was continued at the secondary temperature for 10 h. After the reaction was completed, the temperature was lowered to room temperature, 4.4 kg of methanol was added, and the mixture was extracted twice. 2.2 kg of water was added and washed twice. Subsequently, 700 g of anhydrous magnesium sulfate was added, and the anhydrous magnesium sulfate was removed by filtration after stirring for 30 min. Subsequently, 300 g of activated carbon was added, and the activated carbon was removed by filtration after stirring for 30 min. After concentration, column purification was performed (the ratio of eluent was petroleum ether: n-hexane = 1:20). After elution and concentration, 4.83 kg of colorless transparent liquid was obtained, with a purity of 99.33% and a yield of 85.59%.
[0041] It can be seen from the above examples that ascorbic acid tetraisopalmitate synthesized by the ester exchange method has higher purity and yield than the traditional method, and is simple to operate, does not require acylating agents and strong oxidizing agents, and is conducive to industrial scale-up production.
[0042] The above description is only a preferred specific implementation manner of the present invention, but the protection scope of the present invention is not limited thereto. Any technician familiar with the technical field can make equivalent replacements or changes according to the technical scheme and inventive concept of the present invention within the technical scope disclosed by the present invention, which should be covered by the protection scope of the present invention.
Claims
1. A method for synthesizing ascorbyl tetraisopalmitate, characterized in that: The steps include: Step (1), dissolving methyl 2-hexyldecanoate, vitamin C, and a catalyst in an organic solvent to obtain a suspension solution; Step (2), heating the suspension to reflux and reacting at the reflux temperature for 4 to 10 hours; Step (3), after the reaction is completed, the temperature is lowered to room temperature, and the reaction solution is extracted twice to remove the unreacted 2-hexyldecanoic acid methyl ester; Step (4), after extraction, add water to wash twice to remove the unreacted vitamin C; after washing, add anhydrous magnesium sulfate to dry, and filter to remove the magnesium sulfate; Step (5), activated carbon is added to the filtrate for decolorization. After the decolorization is complete, the filtrate is concentrated. The crude product is purified by a column and concentrated to dryness to obtain a colorless transparent oily liquid, i.e., ascorbyl tetraisopalmitate.
2. A method for synthesizing ascorbyl tetraisopalmitate according to claim 1, characterized in that: The molar ratio of vitamin C to 2-hexyldecanoic acid methyl ester and catalyst in step (1) is 1:4.0-5.0:0.1-1.
0.
3. A method for synthesizing ascorbyl tetraisopalmitate according to claim 1, characterized in that: The catalyst in step (1) is an ester exchange alkaline catalyst, including but not limited to one or more of dibutyltin oxide, DMAP, alkaline resin, etc.
4. A method for synthesizing ascorbyl tetraisopalmitate according to claim 1, characterized in that: The organic solvent in step (1) includes, but is not limited to, one or more of n-hexane, n-heptane, carbon tetrachloride, etc.
5. A method for synthesizing ascorbyl tetraisopalmitate according to claim 1, characterized in that: The reaction time in step (2) is 4 to 10 hours.
6. A method for synthesizing ascorbyl tetraisopalmitate according to claim 1, characterized in that: The extraction solvent in step (3) includes, but is not limited to, one or more of methanol, ethanol, n-octanol, etc.
7. A method for synthesizing ascorbyl tetraisopalmitate according to claim 1, characterized in that: The amount of anhydrous magnesium sulfate used in step (4) is 0.5% to 10% of the weight of the reaction solution.
8. A method for synthesizing ascorbyl tetraisopalmitate according to claim 1, characterized in that: The amount of activated carbon used in step (5) is 0.1% to 10% of the weight of the reaction solution.
9. A method for synthesizing ascorbyl tetraisopalmitate according to claim 1, characterized in that: The ratio of the column purification eluent in step (5) is petroleum ether: normal hexane = 1: 1-50.
Citation Information
Cited By
Process for catalytically synthesizing ascorbyl tetraisopalmitate through biological enzyme
CN120989065A
